Quad Tx in ASCT Eligible NDMM
The Impact of Quadruplet Therapy Incorporating CD38 Antibodies in Transplant-Eligible Patients With NDMM

Released: June 11, 2024

Expiration: June 10, 2025

Michele Cavo
Michele Cavo, MD

Activity

Progress
1
Course Completed